Literature DB >> 15106121

DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4).

Ying-Zhang Chen1, Craig L Bennett, Huy M Huynh, Ian P Blair, Imke Puls, Joy Irobi, Ines Dierick, Annette Abel, Marina L Kennerson, Bruce A Rabin, Garth A Nicholson, Michaela Auer-Grumbach, Klaus Wagner, Peter De Jonghe, John W Griffin, Kenneth H Fischbeck, Vincent Timmerman, David R Cornblath, Phillip F Chance.   

Abstract

Juvenile amyotrophic lateral sclerosis (ALS4) is a rare autosomal dominant form of juvenile amyotrophic lateral sclerosis (ALS) characterized by distal muscle weakness and atrophy, normal sensation, and pyramidal signs. Individuals affected with ALS4 usually have an onset of symptoms at age <25 years, a slow rate of progression, and a normal life span. The ALS4 locus maps to a 1.7-Mb interval on chromosome 9q34 flanked by D9S64 and D9S1198. To identify the molecular basis of ALS4, we tested 19 genes within the ALS4 interval and detected missense mutations (T3I, L389S, and R2136H) in the Senataxin gene (SETX). The SETX gene encodes a novel 302.8-kD protein. Although its function remains unknown, SETX contains a DNA/RNA helicase domain with strong homology to human RENT1 and IGHMBP2, two genes encoding proteins known to have roles in RNA processing. These observations of ALS4 suggest that mutations in SETX may cause neuronal degeneration through dysfunction of the helicase activity or other steps in RNA processing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15106121      PMCID: PMC1182077          DOI: 10.1086/421054

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  25 in total

1.  Conversion of diploidy to haploidy.

Authors:  H Yan; N Papadopoulos; G Marra; C Perrera; J Jiricny; C R Boland; H T Lynch; R B Chadwick; A de la Chapelle; K Berg; J R Eshleman; W Yuan; S Markowitz; S J Laken; C Lengauer; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

Review 2.  DExD/H box RNA helicases: from generic motors to specific dissociation functions.

Authors:  N K Tanner; P Linder
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

3.  NERVE CONDUCTION AND OTHER STUDIES IN FAMILIES WITH CHARCOT-MARIE-TOOTH DISEASE.

Authors:  N C MYRIANTHOPOULOS; M H LANE; D H SILBERBERG; B L VINCENT
Journal:  Brain       Date:  1964-12       Impact factor: 13.501

4.  Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1.

Authors:  K Grohmann; M Schuelke; A Diers; K Hoffmann; B Lucke; C Adams; E Bertini; H Leonhardt-Horti; F Muntoni; R Ouvrier; A Pfeufer; R Rossi; L Van Maldergem; J M Wilmshurst; T F Wienker; M Sendtner; S Rudnik-Schöneborn; K Zerres; C Hübner
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

5.  Characterization of a nuclear 20S complex containing the survival of motor neurons (SMN) protein and a specific subset of spliceosomal Sm proteins.

Authors:  G Meister; D Bühler; B Laggerbauer; M Zobawa; F Lottspeich; U Fischer
Journal:  Hum Mol Genet       Date:  2000-08-12       Impact factor: 6.150

6.  A gene for autosomal dominant juvenile amyotrophic lateral sclerosis (ALS4) localizes to a 500-kb interval on chromosome 9q34.

Authors:  I P Blair; C L Bennett; A Abel; B A Rabin; J W Griffin; K H Fischbeck; D R Cornblath; P F Chance
Journal:  Neurogenetics       Date:  2000-09       Impact factor: 2.660

7.  The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis.

Authors:  Y Yang; A Hentati; H X Deng; O Dabbagh; T Sasaki; M Hirano; W Y Hung; K Ouahchi; J Yan; A C Azim; N Cole; G Gascon; A Yagmour; M Ben-Hamida; M Pericak-Vance; F Hentati; T Siddique
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

8.  Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene.

Authors:  H Date; O Onodera; H Tanaka; K Iwabuchi; K Uekawa; S Igarashi; R Koike; T Hiroi; T Yuasa; Y Awaya; T Sakai; T Takahashi; H Nagatomo; Y Sekijima; I Kawachi; Y Takiyama; M Nishizawa; N Fukuhara; K Saito; S Sugano; S Tsuji
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

9.  A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2.

Authors:  S Hadano; C K Hand; H Osuga; Y Yanagisawa; A Otomo; R S Devon; N Miyamoto; J Showguchi-Miyata; Y Okada; R Singaraja; D A Figlewicz; T Kwiatkowski; B A Hosler; T Sagie; J Skaug; J Nasir; R H Brown; S W Scherer; G A Rouleau; M R Hayden; J E Ikeda
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

10.  A functional interaction between the survival motor neuron complex and RNA polymerase II.

Authors:  L Pellizzoni; B Charroux; J Rappsilber; M Mann; G Dreyfuss
Journal:  J Cell Biol       Date:  2001-01-08       Impact factor: 10.539

View more
  275 in total

Review 1.  Local RNA translation at the synapse and in disease.

Authors:  Liqun Liu-Yesucevitz; Gary J Bassell; Aaron D Gitler; Anne C Hart; Eric Klann; Joel D Richter; Stephen T Warren; Benjamin Wolozin
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 2.  Complex genetics of amyotrophic lateral sclerosis.

Authors:  Catherine B Kunst
Journal:  Am J Hum Genet       Date:  2004-10-11       Impact factor: 11.025

Review 3.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

Review 4.  Familial Amyotrophic Lateral Sclerosis.

Authors:  Kevin Boylan
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

Review 5.  Toward precision medicine in amyotrophic lateral sclerosis.

Authors:  Zhang-Yu Zou; Chang-Yun Liu; Chun-Hui Che; Hua-Pin Huang
Journal:  Ann Transl Med       Date:  2016-01

6.  Integrative analysis of the melanoma transcriptome.

Authors:  Michael F Berger; Joshua Z Levin; Krishna Vijayendran; Andrey Sivachenko; Xian Adiconis; Jared Maguire; Laura A Johnson; James Robinson; Roel G Verhaak; Carrie Sougnez; Robert C Onofrio; Liuda Ziaugra; Kristian Cibulskis; Elisabeth Laine; Jordi Barretina; Wendy Winckler; David E Fisher; Gad Getz; Matthew Meyerson; David B Jaffe; Stacey B Gabriel; Eric S Lander; Reinhard Dummer; Andreas Gnirke; Chad Nusbaum; Levi A Garraway
Journal:  Genome Res       Date:  2010-02-23       Impact factor: 9.043

7.  Ataxia with oculomotor apraxia type 2 fibroblasts exhibit increased susceptibility to oxidative DNA damage.

Authors:  Ricardo H Roda; Carlo Rinaldi; Rajat Singh; Alice B Schindler; Craig Blackstone
Journal:  J Clin Neurosci       Date:  2014-05-06       Impact factor: 1.961

8.  Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery.

Authors:  Mariàngels de Planell-Saguer; David G Schroeder; Maria Celina Rodicio; Gregory A Cox; Zissimos Mourelatos
Journal:  Hum Mol Genet       Date:  2009-03-19       Impact factor: 6.150

Review 9.  RNA processing and its regulation: global insights into biological networks.

Authors:  Donny D Licatalosi; Robert B Darnell
Journal:  Nat Rev Genet       Date:  2010-01       Impact factor: 53.242

10.  Identification and characterisation of a large senataxin (SETX) gene duplication in ataxia with ocular apraxia type 2 (AOA2).

Authors:  Larissa Arning; Ludger Schöls; Huriye Cin; Manfred Souquet; Jörg T Epplen; Dagmar Timmann
Journal:  Neurogenetics       Date:  2008-07-29       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.